Global and local integrated gradient-based diffusion model for de novo drug design
Briefings in Bioinformatics · 07.01.2026 · 27 (1)
DOI: 10.1093/bib/bbag033 ↗Kurz gefasst
Fachartikel in der Zeitschrift Briefings in Bioinformatics, online erschienen am 05.02.2026. Verfasst von Sejin Park und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Electrical Engineering and Computer Science, Gwangju Institute of Science and Technology, 123 Cheomdangwagi-ro, Buk-gu,Gwangju 61005, R…. Hauptthemen laut MEDLINE: Drug Design, Deep Learning. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea, Korean government (MSIT), Institute of Information & Communications Technology Planning & Evaluation (IITP).
Abstract (Originalsprache)
In de novo drug design, deep learning-based approaches have become essential to efficiently navigate the vast chemical space of drug-like molecules. Recently, diffusion-based models have attracted significant attention in the generation of target-binding molecules. However, these models have difficulty in simultaneously optimizing the binding affinity and drug-like properties and require high computational costs because of the long and sequential denoising process. To address these limitations, we propose the Global and local integrated gradient-based Diffusion Model (GlintDM). GlintDM introduces a significantly faster denoising process, namely skip transition, by leveraging global gradients and local gradients. Due to the fast denoising process, GlintDM can perform the following three phases during the molecule generation: position refinement, candidate evaluation, and ligand resampling. These phases allow GlintDM to identify optimal binding positions to the target protein and generate molecules satisfying multi-objective molecular properties. As a result, GlintDM outperforms other methods on both the CrossDocked and Binding MOAD datasets for Vina-related scores. Further validation through the PoseBusters test and assessment of molecular properties, such as steric clash and geometric properties, confirm that GlintDM can generate stable and high-quality molecules.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Electrical Engineering and Computer Science, Gwangju Institute of Science and Technology, 123 Cheomdangwagi-ro, Buk-gu,Gwangju 61005, Republic of Korea.
- Department of Artificial Intelligence Convergence, Gwangju Institute of Science and Technology, 123 Cheomdangwagi-ro, Buk-gu,Gwangju 61005, Republic of Korea.
- GIST InnoCORE AI-Nano Convergence Institute for Early Detection of Neurodegenerative Diseases, Gwangju Institute of Science and Technology, 123 Cheomdangwagi-ro, Buk-gu, Gwangju 61005, Republic of Korea.
ORCID-Profile: Hyunju Lee
Förderung
- National Research Foundation of Korea
- Korean government (MSIT)
- Institute of Information & Communications Technology Planning & Evaluation (IITP)
- Development of Intelligent SW Systems for Uncovering Genetic Variation
- Developing Personalized Medicine for Cancer Patients
- Unknown Molecular Genetic Mechanisms
- Artificial Intelligence Graduate School Program (GIST))
- InnoCORE program of the Ministry of Science and ICT
Zitieren
APA
Park, S., Chung, M., & Lee, H. (2026). Global and local integrated gradient-based diffusion model for de novo drug design. Briefings in Bioinformatics, 27(1). https://doi.org/10.1093/bib/bbag033
Vancouver
Park S, Chung M, Lee H. Global and local integrated gradient-based diffusion model for de novo drug design. Briefings in Bioinformatics. 2026;27(1). doi:10.1093/bib/bbag033
BibTeX
@article{Park2026,
author = {Park, Sejin and Chung, Minjae and Lee, Hyunju},
title = {Global and local integrated gradient-based diffusion model for de novo drug design},
journal = {Briefings in Bioinformatics},
year = {2026},
volume = {27},
number = {1},
doi = {10.1093/bib/bbag033}
}
EUVIMED